Click for best price
Molecular Diagnosis of Tumors Market Size, Share 2024
The global Molecular Diagnosis of Tumors market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
NGS-Based Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis of Tumors include Abbott Laboratories, Roche Holding, Thermo Fisher Scientific, Danaher Corporation, Veracyte, TBG Diagnostics, Agilient Technologies, Illumina and Genecast, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis of Tumors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis of Tumors. This report contains market size and forecasts of Molecular Diagnosis of Tumors in global, including the following market information:
- Global Molecular Diagnosis of Tumors Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Molecular Diagnosis of Tumors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis of Tumors Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Molecular Diagnosis of Tumors Market Segment Percentages, by Type, 2023 (%)
Global Molecular Diagnosis of Tumors Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Molecular Diagnosis of Tumors Market Segment Percentages, by Application, 2023 (%)
- Hospitals
- Diagnostic Centers
- Others
Global Molecular Diagnosis of Tumors Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Molecular Diagnosis of Tumors Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Molecular Diagnosis of Tumors revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Molecular Diagnosis of Tumors revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Roche Holding
- Thermo Fisher Scientific
- Danaher Corporation
- Veracyte
- TBG Diagnostics
- Agilient Technologies
- Illumina
- Genecast
- Burning Rock Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnosis of Tumors, market overview.
Chapter 2: Global Molecular Diagnosis of Tumors market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnosis of Tumors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnosis of Tumors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Molecular Diagnosis of Tumors Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnosis of Tumors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnosis of Tumors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnosis of Tumors Overall Market Size
2.1 Global Molecular Diagnosis of Tumors Market Size: 2023 VS 2030
2.2 Global Molecular Diagnosis of Tumors Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnosis of Tumors Players in Global Market
3.2 Top Global Molecular Diagnosis of Tumors Companies Ranked by Revenue
3.3 Global Molecular Diagnosis of Tumors Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnosis of Tumors Companies in Global Market, by Revenue in 2023
3.5 Global Companies Molecular Diagnosis of Tumors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnosis of Tumors Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnosis of Tumors Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnosis of Tumors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnosis of Tumors Market Size Markets, 2023 & 2030
4.1.2 NGS-Based
4.1.3 PCR-Based
4.2 By Type - Global Molecular Diagnosis of Tumors Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnosis of Tumors Revenue, 2019-2024
4.2.2 By Type - Global Molecular Diagnosis of Tumors Revenue, 2025-2030
4.2.3 By Type - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnosis of Tumors Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 By Application - Global Molecular Diagnosis of Tumors Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnosis of Tumors Revenue, 2019-2024
5.2.2 By Application - Global Molecular Diagnosis of Tumors Revenue, 2025-2030
5.2.3 By Application - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnosis of Tumors Market Size, 2023 & 2030
6.2 By Region - Global Molecular Diagnosis of Tumors Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnosis of Tumors Revenue, 2019-2024
6.2.2 By Region - Global Molecular Diagnosis of Tumors Revenue, 2025-2030
6.2.3 By Region - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Molecular Diagnosis of Tumors Revenue, 2019-2030
6.3.2 US Molecular Diagnosis of Tumors Market Size, 2019-2030
6.3.3 Canada Molecular Diagnosis of Tumors Market Size, 2019-2030
6.3.4 Mexico Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnosis of Tumors Revenue, 2019-2030
6.4.2 Germany Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.3 France Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.4 U.K. Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.5 Italy Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.6 Russia Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.7 Nordic Countries Molecular Diagnosis of Tumors Market Size, 2019-2030
6.4.8 Benelux Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnosis of Tumors Revenue, 2019-2030
6.5.2 China Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.3 Japan Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.4 South Korea Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.5 Southeast Asia Molecular Diagnosis of Tumors Market Size, 2019-2030
6.5.6 India Molecular Diagnosis of Tumors Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Molecular Diagnosis of Tumors Revenue, 2019-2030
6.6.2 Brazil Molecular Diagnosis of Tumors Market Size, 2019-2030
6.6.3 Argentina Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnosis of Tumors Revenue, 2019-2030
6.7.2 Turkey Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7.3 Israel Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7.4 Saudi Arabia Molecular Diagnosis of Tumors Market Size, 2019-2030
6.7.5 UAE Molecular Diagnosis of Tumors Market Size, 2019-2030
7 Molecular Diagnosis of Tumors Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Molecular Diagnosis of Tumors Major Product Offerings
7.1.4 Abbott Laboratories Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Roche Holding
7.2.1 Roche Holding Company Summary
7.2.2 Roche Holding Business Overview
7.2.3 Roche Holding Molecular Diagnosis of Tumors Major Product Offerings
7.2.4 Roche Holding Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.2.5 Roche Holding Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Molecular Diagnosis of Tumors Major Product Offerings
7.3.4 Thermo Fisher Scientific Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Company Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Molecular Diagnosis of Tumors Major Product Offerings
7.4.4 Danaher Corporation Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.4.5 Danaher Corporation Key News & Latest Developments
7.5 Veracyte
7.5.1 Veracyte Company Summary
7.5.2 Veracyte Business Overview
7.5.3 Veracyte Molecular Diagnosis of Tumors Major Product Offerings
7.5.4 Veracyte Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.5.5 Veracyte Key News & Latest Developments
7.6 TBG Diagnostics
7.6.1 TBG Diagnostics Company Summary
7.6.2 TBG Diagnostics Business Overview
7.6.3 TBG Diagnostics Molecular Diagnosis of Tumors Major Product Offerings
7.6.4 TBG Diagnostics Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.6.5 TBG Diagnostics Key News & Latest Developments
7.7 Agilient Technologies
7.7.1 Agilient Technologies Company Summary
7.7.2 Agilient Technologies Business Overview
7.7.3 Agilient Technologies Molecular Diagnosis of Tumors Major Product Offerings
7.7.4 Agilient Technologies Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.7.5 Agilient Technologies Key News & Latest Developments
7.8 Illumina
7.8.1 Illumina Company Summary
7.8.2 Illumina Business Overview
7.8.3 Illumina Molecular Diagnosis of Tumors Major Product Offerings
7.8.4 Illumina Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.8.5 Illumina Key News & Latest Developments
7.9 Genecast
7.9.1 Genecast Company Summary
7.9.2 Genecast Business Overview
7.9.3 Genecast Molecular Diagnosis of Tumors Major Product Offerings
7.9.4 Genecast Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.9.5 Genecast Key News & Latest Developments
7.10 Burning Rock Biotech
7.10.1 Burning Rock Biotech Company Summary
7.10.2 Burning Rock Biotech Business Overview
7.10.3 Burning Rock Biotech Molecular Diagnosis of Tumors Major Product Offerings
7.10.4 Burning Rock Biotech Molecular Diagnosis of Tumors Revenue in Global Market (2019-2024)
7.10.5 Burning Rock Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnosis of Tumors Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnosis of Tumors Market Drivers in Global Market
Table 3. Molecular Diagnosis of Tumors Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnosis of Tumors in Global Market
Table 5. Top Molecular Diagnosis of Tumors Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Molecular Diagnosis of Tumors Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Molecular Diagnosis of Tumors Revenue Share by Companies, 2019-2024
Table 8. Global Companies Molecular Diagnosis of Tumors Product Type
Table 9. List of Global Tier 1 Molecular Diagnosis of Tumors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnosis of Tumors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Molecular Diagnosis of Tumors Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Molecular Diagnosis of Tumors Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Molecular Diagnosis of Tumors Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Molecular Diagnosis of Tumors Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Molecular Diagnosis of Tumors Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Molecular Diagnosis of Tumors Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Molecular Diagnosis of Tumors Product Offerings
Table 32. Abbott Laboratories Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Roche Holding Company Summary
Table 35. Roche Holding Molecular Diagnosis of Tumors Product Offerings
Table 36. Roche Holding Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 37. Roche Holding Key News & Latest Developments
Table 38. Thermo Fisher Scientific Company Summary
Table 39. Thermo Fisher Scientific Molecular Diagnosis of Tumors Product Offerings
Table 40. Thermo Fisher Scientific Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 41. Thermo Fisher Scientific Key News & Latest Developments
Table 42. Danaher Corporation Company Summary
Table 43. Danaher Corporation Molecular Diagnosis of Tumors Product Offerings
Table 44. Danaher Corporation Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 45. Danaher Corporation Key News & Latest Developments
Table 46. Veracyte Company Summary
Table 47. Veracyte Molecular Diagnosis of Tumors Product Offerings
Table 48. Veracyte Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 49. Veracyte Key News & Latest Developments
Table 50. TBG Diagnostics Company Summary
Table 51. TBG Diagnostics Molecular Diagnosis of Tumors Product Offerings
Table 52. TBG Diagnostics Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 53. TBG Diagnostics Key News & Latest Developments
Table 54. Agilient Technologies Company Summary
Table 55. Agilient Technologies Molecular Diagnosis of Tumors Product Offerings
Table 56. Agilient Technologies Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 57. Agilient Technologies Key News & Latest Developments
Table 58. Illumina Company Summary
Table 59. Illumina Molecular Diagnosis of Tumors Product Offerings
Table 60. Illumina Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 61. Illumina Key News & Latest Developments
Table 62. Genecast Company Summary
Table 63. Genecast Molecular Diagnosis of Tumors Product Offerings
Table 64. Genecast Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 65. Genecast Key News & Latest Developments
Table 66. Burning Rock Biotech Company Summary
Table 67. Burning Rock Biotech Molecular Diagnosis of Tumors Product Offerings
Table 68. Burning Rock Biotech Molecular Diagnosis of Tumors Revenue (US$, Mn) & (2019-2024)
Table 69. Burning Rock Biotech Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnosis of Tumors Segment by Type in 2023
Figure 2. Molecular Diagnosis of Tumors Segment by Application in 2023
Figure 3. Global Molecular Diagnosis of Tumors Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnosis of Tumors Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Molecular Diagnosis of Tumors Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnosis of Tumors Revenue in 2023
Figure 8. By Type - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 9. By Application - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 10. By Type - Global Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 12. By Application - Global Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 14. By Region - Global Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 15. By Country - North America Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 16. US Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 20. Germany Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 21. France Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 28. China Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 32. India Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 34. Brazil Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Molecular Diagnosis of Tumors Revenue Market Share, 2019-2030
Figure 37. Turkey Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Molecular Diagnosis of Tumors Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Laboratories Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Roche Holding Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Thermo Fisher Scientific Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Danaher Corporation Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Veracyte Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. TBG Diagnostics Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Agilient Technologies Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Illumina Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Genecast Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Burning Rock Biotech Molecular Diagnosis of Tumors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
